Adil el Housseini | Cellular Neuroscience | Best Researcher Award

Mr. Adil el Housseini | Cellular Neuroscience | Best Researcher Award

Mr. Adil el Housseini | Ibn Zohr University Agadir Morocco | Morocco

Adil EL Housseini is a dedicated PhD candidate in biology at Ibn Zohr University, Faculty of Sciences of Agadir, specializing in toxicology, biochemistry, and the molecular characterization of scorpion venoms. His doctoral research explores the biochemical composition, ecotoxicity, and pathophysiological mechanisms of venoms from selected Buthid species, with a particular focus on developing novel therapeutic strategies for scorpion envenomation. Adil has contributed to the scientific community through peer-reviewed publications and authored book chapters spanning biomedical polymers, chitosan-based therapeutic applications, radioprotective biomaterials, and neurobiological insights into astrocyte function. His work on the kinetics of brain oxidative stress following scorpion envenomation highlights his strong command of experimental toxicology and neurobiochemical analysis. With an h-index of 1, two indexed documents, and two citations, he continues to build a research profile grounded in rigorous experimentation and interdisciplinary scientific inquiry. Adil’s skills include venom biochemistry, laboratory toxicology, data interpretation, and scientific writing, supported by strong language proficiency in Arabic, French, and English. His commitment to advancing knowledge in venom toxicology and biomedical sciences positions him as a promising emerging researcher contributing to both fundamental understanding and applied therapeutic innovation.

Profile: Google Scholar | Orcid

Featured Publications

Ait Hamdan, Y., Rhazi, M., El-Mansoury, B., Kabdy, H., Oukhrib, M., Ait Baba, A., … (2024). Astrocytes functions and their involvement in brain injury: A focus on the biomaterials’ role in mitigating traumatic brain injury. In Physiology and Function of Glial Cells in Health and Disease (pp. 145–163).

Mabsor-Zgandaoui, S., Rachmoune, K., Aftais, I., Elamrani, F. E., Amradi, I., … (2026). Biomedical polymers: Foundations and future innovations in medicine. In Biomedical Applications and Toxicity of Polymers, Nanoparticles

Ait Hamdan, Y., Armadi, I., Elamrani, F. E., Mekouar, M., El Housseini, A., … (2026). Therapeutic implications of chitosan and its derivatives: Focus on cancer treatment. In Biomedical Applications and Toxicity of Polymers, Nanoparticles

Rachmoune, K., Mabsor-Zgandaoui, S., El Housseini, A., Ait Hamdan, Y., … (2026). Radioprotective effects of chitosan polysaccharides and biomedical applications. In Biomedical Applications and Toxicity of Polymers, Nanoparticles

Armadi, I., Elouali, S., Abana, A., El Housseini, A., Loqman, S., & Belbachir, A. (2025). Overview of biomaterials classification, properties, and biomedical applications. In Innovations and Applications of Advanced Biomaterials in Healthcare 

Sukesh Sinha | Neuropharmacology | Lifetime achievement Award

Prof. Dr. Sukesh Sinha | Neuropharmacology | Lifetime achievement Award

Prof. Dr. Sukesh Sinha,  National Institute of Nutrition-ICMR, India.

Dr. Sukesh Narayan Sinha, a seasoned toxicologist and research leader, has dedicated his career to advancing the fields of food safety, drug toxicology, pesticide toxicology, and pharmacology. Starting with a strong academic foundation in chemistry from Bihar University, he honed his expertise further through international training at the University of Helsinki and the CDC in the USA. Rising through the ranks of India’s premier health research institutions under the ICMR, Dr. Sinha’s career spans critical research roles that have directly impacted national health and safety policies. His global collaborations and leadership roles reflect a career built on scientific rigor, public service, and continuous learning.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Born on January 3rd, 1965, Dr. Sukesh Narayan Sinha’s academic journey began with a profound interest in the field of chemistry. He earned his B.Sc. Honours in Chemistry in 1989, followed by an M.Sc. in Chemistry in 1993, and later a Ph.D. in Chemistry in 1999—all from Bihar University, Muzaffarpur. His pursuit of advanced scientific knowledge extended internationally, where he underwent specialized analytical skill development in toxicology at the University of Helsinki, Finland. These foundational years cemented his passion for chemical and toxicological research, shaping the path for a distinguished career in public health and environmental safety.

🧪 Professional Endeavors in Toxicology

Dr. Sinha’s career has been marked by continuous progression through India’s foremost medical and research institutions under the Indian Council of Medical Research (ICMR). Beginning as a Research Fellow at the National Institute of Malaria Research, he moved into industry as a Research Scientist at Alkame Laboratory. His return to the ICMR system in 2001 marked the beginning of a steady ascent through scientific ranks—from Scientist-B to his current post as Senior Grade Deputy Director (Scientist-F) at the ICMR-National Institute of Nutrition (NIN), Hyderabad. He also held key roles at the ICMR-National Institute of Occupational Health, contributing immensely to occupational and environmental health research.

🧬 Contributions and Research Focus

Specializing in Food Toxicology, Drug Research & Toxicology, Pesticide Toxicology, and Pharmacology, Dr. Sinha has focused on identifying and mitigating chemical risks in food and the environment. His work has had a direct impact on public health safety standards in India. Through advanced analytical techniques and interdisciplinary collaboration, he has played a central role in guiding policy and regulatory frameworks concerning food safety. His expertise has not only contributed to toxicological research but has also enhanced national capacities in monitoring hazardous substances affecting human health.

🌍 Global Collaborations and Scientific Exposure

Dr. Sinha’s vision and research have reached global platforms. Notably, he served as a Visiting Scientist at the University of Cincinnati, USA, where he collaborated with experts in Environmental Health. He also completed two intensive courses on health and safety under the Centers for Disease Control and Prevention (CDC) in Atlanta, USA. These international exposures have enriched his scientific perspective, enabling him to incorporate global best practices into India’s health safety frameworks and toxicology research protocols.

🏅 Accolades and Recognition

Throughout his career, Dr. Sinha has earned recognition for his commitment and excellence in scientific research. While specific awards are not listed, his steady promotion within the ICMR ranks—from Scientist-B to Scientist-F—reflects institutional trust in his capabilities and leadership. His selection as a visiting scientist abroad and participation in elite training programs also underscore his status as a respected voice in toxicology and public health research.

📢 Impact and Influence on Public Health

Through his extensive research and governmental role, Dr. Sinha has contributed to national strategies on food safety and toxic substance regulation. His input influences decisions affecting millions of citizens, especially in areas related to food contaminants, drug residues, and environmental pollutants. He continues to serve as a bridge between laboratory research and real-world applications that safeguard public health in India.

🔬 Legacy and Future Contributions

Dr. Sinha’s legacy lies in his unwavering commitment to science and service. With decades of experience and an expanding portfolio of national and international collaborations, he is poised to continue influencing future research, shaping young scientific minds, and contributing to India’s health security. His role at ICMR-NIN ensures that his insights and leadership will guide public health policies and toxicology advancements for years to come.

Publication

  • Quantification of organophosphate insecticides and herbicides in vegetable samples using the “Quick Easy Cheap Effective Rugged and Safe” (QuEChERS) method and a high …
    SN Sinha, K Vasudev, MVV Rao2012

 

  • Distribution of pesticides in different commonly used vegetables from Hyderabad, India
    SN Sinha, MVV Rao, K Vasudev2012

 

  • Air pollution from solid fuels.
    SN Sinha, PK Nag2011

 

  • Environmental monitoring of benzene and toluene produced in indoor air due to combustion of solid biomass fuels
    SN Sinha, PK Kulkarni, SH Shah, NM Desai, GM Patel, MM Mansuri, …2006

 

  • Repeated episodes of endosulfan poisoning
    A Dewan, VK Bhatnagar, ML Mathur, T Chakma, R Kashyap, HG Sadhu, …2004

 

  • Effect of dissociation energy on ion formation and sensitivity of an analytical method for determination of chlorpyrifos in human blood, using gas chromatography–mass …
    SN Sinha, R Pal, A Dewan, MM Mansuri, HN Saiyed2006

 

  • A novel method for pesticide analysis in refined sugar samples using a gas chromatography–mass spectrometer (GC–MS/MS) and simple solvent extraction method
    SN Sinha, VK Bhatnagar, P Doctor, GS Toteja, NP Agnihotri, RL Kalra2011

 

  • A liquid chromatography mass spectrometry-based method to measure organophosphorous insecticide, herbicide and non-organophosphorous pesticide in grape and apple samples
    SN Sinha, MVV Rao, K Vasudev, M Odetokun2012

 

  • Quantification of organophosphate insecticides in drinking water in urban areas using lyophilization and high-performance liquid chromatography–electrospray ionization-mass …
    SN Sinha, K Vasudev, MVV Rao, M Odetokun2011

 

  • Inhibition of protein glycation by procyanidin‐B2 enriched fraction of cinnamon: delay of diabetic cataract in rats
    P Muthenna, G Raghu, C Akileshwari, SN Sinha, P Suryanarayana, …2013

 

🏁 Conclusion

Dr. Sukesh Narayan Sinha stands as a respected figure in India’s scientific community, with an enduring impact on toxicology research and public health safety. His career reflects a seamless integration of deep scientific knowledge, practical application, and international collaboration. As he continues his service at ICMR-NIN, his contributions promise to leave a lasting legacy in strengthening food safety standards, environmental health, and public policy for future generations. Dr. Sinha’s journey inspires commitment to research excellence and exemplifies the profound role of science in safeguarding society.

 

Lijuan Song | Cellular Neuroscience | Best Researcher Award

Prof. Lijuan Song | Cellular Neuroscience | Best Researcher Award

Prof. Lijuan Song,  Shanxi University of Chinese Medicine, China.

Throughout my career, I have passionately committed myself to integrating traditional Chinese medicine and Western medicine to advance the prevention and treatment of brain diseases, particularly ischemic cerebrovascular diseases and neurodegenerative disorders. By leading 14 national and provincial-level research projects, publishing over 130 academic papers, and contributing significantly to educational reform, I have built a strong foundation of scientific innovation and clinical excellence. With achievements recognized both nationally and internationally, and a consistent focus on combining research, teaching, and clinical work, I have significantly impacted the fields of neuroprotection and integrative medicine.

Profile

Scopus

 

🎓 Early Academic Pursuits

From the outset of my academic journey, I committed myself to the profound study of both traditional Chinese medicine and Western medicine, aspiring to bridge these two disciplines for the betterment of brain disease treatment. I pursued a rigorous path of education and research, laying a strong foundation that later allowed me to integrate diverse medical perspectives. Early in my career, I developed a particular interest in ischemic cerebrovascular diseases and neurodegenerative conditions, setting the stage for my lifelong mission to innovate in these critical areas.

🩺 Professional Endeavors

My professional career has been a dynamic blend of teaching, clinical practice, and scientific research, with a special focus on the prevention and treatment of brain diseases. I have successfully presided over 14 prestigious national and provincial-level projects, including those funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Through my work, I have consistently emphasized the value of integrating traditional Chinese medicine with modern Western practices, ensuring that my clinical and research contributions are both culturally rooted and globally relevant.

🔬 Contributions and Research Focus

Throughout my research journey, I have concentrated on ischemic cerebrovascular diseases and neurodegenerative diseases, pioneering integrated approaches for their prevention and treatment. I have published 133 scientific papers, including 45 in SCI-indexed journals, with nearly 700 citations and an H-index of 15. One of my papers published in Neural Regeneration Research (NRR) has been recognized in the ESI highest citation list, achieving an impressive 97 citations. Beyond scientific research, I have also contributed significantly to educational innovation, authoring educational reform articles in the China Journal of Traditional Chinese Medicine and editing influential academic books.

🏆 Accolades and Recognition

My dedication to scientific advancement and education has earned me multiple prestigious honors. As the first author, I received the First Prize of the Academic Achievement Award from the China Association for the Promotion of Traditional Chinese Medicine Research. I have secured three authorized patents and two software copyrights, further showcasing my commitment to innovation. Additionally, my work has been featured through oral presentations at internationally renowned academic forums such as the Autoimmunity Congress and the World Stroke Congress, and recognized by respected platforms like Logic Neuroscience and Neuroweekly.

🌍 Impact and Influence

My influence extends beyond academia into public science education and medical philosophy dialogues. I have been repeatedly invited to deliver popular science talks and academic lectures at events like the Medical Philosophy Expert Meeting Room. My presentation at the 2022 International Neural Regeneration Summit Forum earned the Most Popular Award, affirming my ability to translate complex research into impactful and accessible knowledge for diverse audiences.

📚 Legacy in Education and Publishing

In addition to research and clinical achievements, I have made significant contributions to academic publishing and educational reform. My independently authored book, Progress in Integrated Traditional Chinese and Western Medicine Prevention and Treatment of Ischemic Cerebrovascular Disease, was published by People’s Health Publishing House. I have served as the first editor-in-chief for three important books, including Exploration of Teaching Models in Higher Education Pharmaceutical Education, which was honored by its selection into the “Library of Young Scholars in Universities,” marking a lasting contribution to the future of pharmaceutical education.

🚀 Future Contributions and Aspirations

Looking ahead, I aspire to further deepen the integration of traditional Chinese and Western medicine, particularly in brain disease prevention and therapy. I am committed to leading new research directions, fostering international collaborations, and nurturing a new generation of scholars who value the richness of cross-cultural medical practices. My future endeavors will continue to reflect a relentless pursuit of scientific excellence, compassionate clinical practice, and transformative education for the global health community.

Publication

  • Title: Effect of tetramethylpyrazine on neuroinflammation after cerebral ischemia and hypoxia based on mannose-binding lectin
    Authors: Y. Duan, Yanzhe; J. Hua, Jianlin; Y. Yan, Yuqing; L. Song, Lijuan
    Year: 2025

 

  • Title: Polysaccharides from Ganoderma lucidum attenuate cognitive impairment in 5xFAD mice by inhibiting oxidative stress and modulating mitochondrial dynamics via the Nrf2/antioxidative axis activation
    Authors: J. Yu, Jiezhong; C. Ma, Cungen
    Year: 2025

 

  • Title: Hydroxysafflower yellow A alleviates the inflammatory response in astrocytes following cerebral ischemia by inhibiting the LCN2/STAT3 feedback loop
    Authors: L. Song, Lijuan; Y. Wu, Yige; L. Yin, Lijun; B. Xiao, Baoguo; C. Ma, Cungen
    Year: 2025

 

  • Title: Mechanism of senegenin in improving lipopolysacchride-induced inflammatory response of BV2 microglial cell
    Authors: B. Mu, Bingtao; M. Guo, Minfang; J. Yu, Jingwen; J. Yu, Jiezhong; L. Song, Lijuan
    Year: 2025

 

  • Title: Effectiveness and Safety of Blending Traditional Chinese Medicine With Western Medicine for Enhanced Secondary Stroke Prevention: A Meta-analysis of RCTs
    Authors: C. Wen, Chunli; L. Song, Lijuan; C. Ma, Cungen; F. Hu, Fengyun; L. Zhu, Linggqun
    Year: 2025

 

 

🎯 Conclusion

Driven by a deep belief in the power of integration between ancient wisdom and modern science, I have continuously sought to pioneer new frontiers in brain disease treatment. My work has not only advanced research but also nurtured future generations through educational contributions and public science communication. Moving forward, I remain committed to expanding the reach and depth of integrated medicine, aiming to create a lasting legacy of innovation, healing, and academic excellence for global healthcare advancement.

Peng Jun | Cellular Neuroscience | Best Researcher Award

Prof. Peng Jun | Cellular Neuroscience | Best Researcher Award

Prof. Peng Jun, Qilu hospital of Shandong University, China.

Professor Jun Peng is a distinguished leader in hematology, currently serving as Vice President of Qilu Hospital of Shandong University and Director of the Department of Hematology. His research is deeply rooted in the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP), where he has made significant breakthroughs, including the publication of 14 papers in Blood. With a career supported by prestigious national awards, and leadership in 15 high-level research projects, Professor Peng is also a vital figure in Chinese hematology societies and editorial boards of leading journals. His academic rigor, clinical insight, and mentorship continue to shape the future of hematological science in China and beyond.

Profile

Scopus

🎓 Early Academic Pursuits

Professor Jun Peng embarked on his academic journey with a strong commitment to medicine and hematological sciences. From the outset, he exhibited exceptional academic talent and dedication, leading him to pursue both an M.D. and Ph.D. His early education laid a robust foundation for his future specialization in hematology, particularly in the complex field of immunological disorders. His doctoral work, recognized nationally, foreshadowed the groundbreaking contributions he would later make in immune thrombocytopenia research.

🩺 Professional Endeavors

Currently serving as the Vice President of Qilu Hospital of Shandong University, Professor Peng also holds the roles of Chief Physician, Professor, and Ph.D./M.D. Advisor, in addition to being the Director of the Department of Hematology. His clinical and academic responsibilities are carried out with unwavering diligence, mentoring future medical experts while overseeing high-level clinical operations. As a Distinguished Professor of Shandong University, he is actively engaged in shaping the university’s medical excellence on both national and global stages.

🔬 Contributions and Research Focus

At the heart of Professor Peng’s career is his pioneering work on the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP). He has made substantial contributions to understanding the autoimmune mechanisms that underlie ITP, one of the most challenging hematologic disorders. His scholarly dedication is evidenced by the publication of 14 papers in Blood, a leading journal in hematology, where he served as corresponding or co-corresponding author. His research, grounded in clinical insight and scientific precision, has contributed new perspectives on immune regulation in hematologic diseases.

🏆 Accolades and Recognition

Professor Peng’s excellence has been recognized with numerous prestigious awards. These include the National Science Fund for Distinguished Young Scholars, which highlights his scientific creativity and impact at a young age. He is also a recipient of the One-Hundred National Outstanding Doctoral Dissertation Award, a testament to the academic rigor of his early research. Additionally, he earned the First Prize of the Natural Science Award for Outstanding Achievements in Scientific Research from the Ministry of Education and the Science and Technology Progress Award, reflecting both his academic brilliance and practical impact in the medical field.

🧪 Impact and Influence

Beyond research publications, Professor Peng has significantly influenced the broader scientific and medical communities. As a principal investigator, he has led fifteen national and ministerial-level research projects, including those funded by the National Natural Science Foundation of China and the 973 Program under the Ministry of Science and Technology. His leadership extends to active roles in national academic societies, including the Thrombosis and Hemostasis Group of the Chinese Society of Hematology and the Professional Committee of Experimental Hematology of the Chinese Society of Pathophysiology. These positions allow him to shape the direction of hematological research and clinical guidelines in China.

📚 Academic Leadership and Editorial Roles

A passionate advocate for knowledge dissemination, Professor Peng is a key editorial board member for several respected journals such as Thrombosis Journal, Thrombosis Research, Journal of Clinical Hematology, and the Chinese Journal of Hematology. Through these roles, he ensures that cutting-edge research in hematology is critically evaluated and shared widely, fostering a culture of scientific excellence and collaboration across the globe.

🌟 Legacy and Future Contributions

Professor Jun Peng’s legacy is being forged not only through his past achievements but also through his continued commitment to the advancement of hematological science. His influence spans clinical innovation, academic mentorship, and scientific discovery. As he continues to push the boundaries of understanding in ITP and immune tolerance, he inspires a new generation of physician-scientists. The impact of his work promises to resonate for years to come, offering hope and healing for patients and propelling China’s medical research onto the world stage.

Publication

  • Title: Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
    Authors: Qizhao Li, Geneviève Marcoux, Yuefen Hu, Jung Peng, John W. Semple
    Year: 2024

 

  • Title: Quantitative detection of macular microvascular abnormalities identified by optical coherence tomography angiography in different hematological diseases
    Authors: Tianzi Jian, Fabao Xu, Guihua Li, Li Zhang, Jung Peng
    Year: 2024

 

  • Title: Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia
    Authors: Ju Li, Cheng Zhang, Yuefen Hu, Qi Feng, Xiang Hu
    Year: 2024

 

  • Title: The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)
    Authors: Lin Sun, Yichen Zhang, Ping Chen, Jung Peng, Zi Sheng
    Year: 2024

 

  • Title: Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review
    Authors: You Yuan Su, Yafei Yu, Zhenyu Yan, Jung Peng, Xinguang Liu
    Year: 2024

 

  • Title: Ion channel Piezo1 activation aggravates the endothelial dysfunction under a high glucose environment
    Authors: Xiaoyu Zhang, Shaoqiu Leng, Xinyue Liu, Shuwen Wang, Jung Peng
    Year: 2024

 

  • Title: Intelligent dual-modality label-free cell classification with light scattering imaging and Raman spectra measurements
    Authors: Faihaa Mohammed Eltigani, Xiaoyu Zhang, Min Liu, Jung Peng, Xuantao Su
    Year: 2024

 

  • Title: Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial
    Authors: Lu Sun, Xiaoyang Huang, Juan Wang, Ming Hou, Yu Hou
    Year: 2024

 

  • Title: Risk Factors for Mortality in Critically Ill Patients with Coagulation Abnormalities: A Retrospective Cohort Study
    Authors: Qiuyu Guo, Jung Peng, Tichao Shan, Miao Xu
    Year: 2024

 

  • Title: Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
    Authors: Lingjun Wang, Haoyi Wang, Mingfang Zhu, Ming Hou, Yu Hou
    Year: 2024

 

✅ Conclusion

Through his pioneering research, unwavering clinical dedication, and impactful academic leadership, Professor Jun Peng stands at the forefront of immuno-hematology. His work not only deepens scientific understanding of ITP but also contributes directly to improved patient outcomes. As he continues to inspire through teaching, research, and innovation, Professor Peng’s legacy is one of excellence, influence, and ongoing transformation in the global hematology community.

 

Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Daša Zupančič, Faculty of Medicine, University of Ljubljana, Slovenia.

Daša Zupančič is a distinguished academic and researcher specializing in cell biology, urothelial pathology, and medical education. Her extensive contributions to scientific research, particularly in the field of urothelial repair and cancer transformation, have earned her recognition, including the EMBO award. She has played a crucial role in mentoring and teaching, guiding future generations of researchers and medical professionals.

Profile

Orcid

✨ Early Academic Pursuits ✨

Daša Zupančič embarked on her academic journey with an unwavering passion for cell biology and medicine. She earned her Master’s degree in 2002 from the University of Ljubljana, Faculty of Medicine, where she meticulously explored cellular and molecular biological changes in the rat bladder urothelium following cyclophosphamide exposure. This formative research laid the foundation for her Ph.D., which she successfully completed in 2006, investigating the protective role of melatonin in urothelial injury and repair. Her dedication to advancing biomedical knowledge was evident from the very beginning of her scholarly career.

🎓 Professional Endeavors 🎓

Since 2006, Daša Zupančič has been an esteemed Associate Professor at the University of Ljubljana, Faculty of Medicine, Institute of Cell Biology. Prior to this, she gained valuable experience as a Young Researcher and Teaching Assistant from 1999 to 2006. Her extensive expertise and commitment to education have made her an integral part of the institution, where she continuously fosters scientific curiosity and excellence among students and colleagues alike.

🎡 Contributions and Research Focus 🎡

Throughout her career, Daša Zupančič has dedicated her research to understanding cellular mechanisms in urothelial biology and pathology. Her investigations into cyclophosphamide-induced urothelial injury, melatonin’s protective effects, and retinoid signaling pathways in urothelial cancer transformation have provided valuable insights into cellular repair processes. Her work extends beyond laboratory research, influencing the medical community’s approach to urothelial diseases and potential therapeutic advancements.

🏆 Accolades and Recognition 🏆

Her exceptional contributions to biomedical research have been recognized on multiple platforms. In 2017, she was honored with the prestigious EMBO award for her short-term scholarship project on the role of the retinoid signaling pathway in urothelial cancer transformation. This recognition underscores her significant impact on the scientific community and highlights her pioneering approach to understanding cancer pathophysiology.

👨‍🎓 Impact and Influence 👨‍🎓

A dedicated mentor, Daša Zupančič has guided numerous students towards academic excellence. Between 2014 and 2025, she has successfully mentored four master’s students and is currently supervising two more. In addition, she has overseen the research endeavors of four Ph.D. candidates, with one having successfully defended their dissertation in 2023 and another expected to graduate in 2025. Her mentorship has shaped the next generation of biomedical researchers, fostering a culture of rigorous inquiry and scientific discovery.

📚 Legacy and Future Contributions 📚

Beyond her research, Daša Zupančič plays a pivotal role in academia through her extensive teaching engagements. Since 2000, she has been a cornerstone of education at the University of Ljubljana, contributing to multiple faculties, including Medicine, Biotechnical Sciences, Health Sciences, and Pharmacy. She teaches a range of graduate and doctoral courses, covering essential subjects such as Medical Cell Biology, Immunology, and Research in Medicine. Her dedication to education ensures that her knowledge and expertise continue to shape the minds of aspiring medical professionals and researchers for years to come.

Publication

  • Vitamin A‐Enriched Diet Increases Urothelial Cell Proliferation by Upregulating Itga3 and Areg After Cyclophosphamide‐Induced Injury in Mice
    Authors: Brina Dragar, Simona Kranjc Brezar, Maja Čemažar, Tanja Jesenko, Rok Romih, Mateja Erdani Kreft, Tadeja Kuret, Daša Zupančič
    Year: 2025

 

  • Selective Targeting of Lectins and Their Macropinocytosis in Urothelial Tumours: Translation from in vitro to ex vivo
    Authors: Nataša Resnik, Tanja Višnjar, Tomaž Smrkolj, Mateja Erdani Kreft, Rok Romih, Daša Zupančič
    Year: 2023

 

  • Nanodiamonds as Possible Tools for Improved Management of Bladder Cancer and Bacterial Cystitis
    Authors: Daša Zupančič, Peter Veranič
    Year: 2022

 

  • Transmission Electron Microscopy Demonstration of Reduced Endothelial Glycocalyx in Severe Preeclampsia
    Authors: Mugerli S, Zupančič D, Rok Romih, Lučovnik M
    Year: 2022

 

  • Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects
    Authors: Larisa Tratnjek, Jera Jeruc, Rok Romih, Daša Zupančič
    Year: 2021

 

  • Immunohistochemistry as a Paramount Tool in Research of Normal Urothelium, Bladder Cancer and Bladder Pain Syndrome
    Authors: Daša Zupančič, Rok Romih
    Year: 2021

 

  • Combined Lectin- and Immuno-Histochemistry (CLIH) for Applications in Cell Biology and Cancer Diagnosis: Analysis of Human Urothelial Carcinomas
    Authors: Daša Zupančič
    Year: 2020

 

  • Vitamin A Rich Diet Diminishes Early Urothelial Carcinogenesis by Altering Retinoic Acid Signaling
    Authors: Daša Zupančič, Jelena Korać-Prlić, Mateja Erdani Kreft, Lucija Franković, Katarina Vilović, Jera Jeruc, Rok Romih, Janoš Terzić
    Year: 2020

 

  • Lectins as Possible Tools for Improved Urinary Bladder Cancer Management
    Authors: Daša Zupančič
    Year: 2019

 

  • Co-Culturing Porcine Normal Urothelial Cells, Urinary Bladder Fibroblasts and Smooth Muscle Cells for Tissue Engineering Research
    Authors: Daša Zupančič
    Year: 2018

 

🌟 Conclusion 🌟

With a career dedicated to pioneering research, impactful mentorship, and transformative education, Daša Zupančič continues to leave a lasting legacy in the scientific and academic communities. Her work not only enhances understanding of urothelial biology but also inspires innovation and discovery among young scientists. As she continues her academic and research endeavors, her influence on the field will undoubtedly grow, shaping the future of biomedical sciences.